Bernstein Downgrades HCA Healthcare to Market Perform, Announces $301 Price Target
Portfolio Pulse from Benzinga Newsdesk
Bernstein analyst Lance Wilkes downgraded HCA Healthcare (NYSE:HCA) from Outperform to Market Perform and set a price target of $301.

January 04, 2024 | 4:51 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bernstein downgraded HCA Healthcare to Market Perform and set a price target of $301.
Downgrades typically lead to a negative perception among investors, potentially causing short-term price decline. However, the new price target of $301 may suggest a limited upside or that the stock is fairly valued, leading to a neutral score.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100